David W. Anderson is Director at REPRO MED SYSTEMS INC (REPR). They have made 6 open-market trades across 2 companies since 2017, most recently 2024-08-29.
CIK 0001304554
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
4 open-market purchases totalling $26K since 2023, against 2 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CTCX | BUY | 2024-08-28 | 2024-08-30 | $0.56 | $785 | N/A | N/A | N/A |
| CTCX | BUY | 2023-12-14 | 2023-12-18 | $3.83 | $4K | N/A | N/A | N/A |
| CTCX | BUY | 2023-12-11 | 2023-12-13 | $4.20 | $14K | N/A | N/A | N/A |
| CTCX | BUY | 2023-12-04 | 2023-12-08 | $3.03 | $7K | N/A | N/A | N/A |
| REPR | SELL | 2017-05-30 | 2017-06-01 | $0.40 | $3K | N/A | +2.1% | +2.1% |
| REPR | SELL | 2017-05-17 | 2017-05-30 | $0.40 | $9K | N/A | +2.1% | +2.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.